Clinical outcomes of His‐Purkinje conduction system pacing
Citations Over TimeTop 11% of 2020 papers
Abstract
His-Purkinje conduction system pacing (HPCSP) in the form of His bundle pacing (HBP) and left bundle branch pacing (LBBP) allows normal left ventricular activation, thereby preventing the adverse consequences of right ventricular pacing. HBP has been established for several years with centers from China, Europe, and North America reporting their experience. There is international guidance as to how to implant such systems with the differing patterns of His bundle capture clearly described. LBBP is a more recent innovation with potential advantages including improved pacing parameters. HPCSP has been extensively studied in a variety of indications including cardiac resynchronization therapy, atrioventricular node ablation, and bradycardia pacing. This review will focus on the clinical outcomes of HPCSP including mortality and morbidity of heart failure hospitalization and symptoms.
Related Papers
- → Immunohistochemical delineation of the conduction system. II: The atrioventricular node and Purkinje fibers.(1993)132 cited
- → Intramural Purkinje Cell Network of Sheep Ventricles as the Terminal Pathway of Conduction System(2008)45 cited
- → A novel transgenic Cre allele to label mouse cardiac conduction system(2021)8 cited
- → Unsolved Questions on the Anatomy of the Ventricular Conduction System(2018)25 cited
- Immunohistochemical delineation of the conduction system. II: The atrioventricular node and Purkinje fibers.(1993)